UK Pharmaceutical Research to be honoured

Fourteen entries will be vying for the prestigious 2006 UK Prix Galien Award it was announced today. The entries are:

• Alvesco - Altana Pharma (Respiratory)
• Alimta - Eli Lilly and Company (Oncology)
• Myozyme - Genzyme Speciality Therapeutics (Metabolic disorders)
• Rotarix - GlaxoSmithKline (Gastroenterology)
• Erbitux - Merck Pharmaceuticals (Oncology)
• Moviprep - Norgine (Gastroenterology)
• Movicol Paediatric (Gastroenterology)
• Xolair - Novartis (Respiratory)
• Aromasin - Pfizer (Oncology)
• Lyrica - Pfizer (Neurology)
• Avastin - Roche (Oncology)
• Tarceva - Roche (Oncology)
• Zevalin - Schering Healthcare (Oncology)
• Protelos - Servier Laboratories (Endocrine system)

The award recognises outstanding achievement in pharmaceutical research and development, and is presented to the most innovative treatment to have been recently developed in the UK.

The independent judging committee members currently range from experts within the National Institute of Clinical Excellence (NICE) and the Scottish Medicines Consortium (SMC) through to leading medical consultants, academics and a media doctor.

When deciding upon the winners they have been asked to identify the medicines that have made the most significant contribution to patient care in the UK. They also judge against broader themes such as efficacy, safety, benefits and innovation.

The overall winning entry will receive the gold Prix Galien medal. Previous winners of this highly prestigious honour are Herceptin, Prevenar and Viagra.

The Awards ceremony will be held at the Houses of Parliament on 26 September 2006.

For further details, or to arrange an interview with Prix Galien judges Professor Sir Michael Rawlins (NICE) or Professor Parveen Kumar (BMA) please contact Sarah Beyrath at Right Angle Learning: Ph: 020 8834 1039 or 07958672239

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Medical examiners to scrutinise deaths in community settings

The MDU's Dr Kathryn Leask explains how the expansion of the medical examiner system...

Person receiving a COVID-19 booster

COVID-19 booster campaign to start on 5 September, NHS England says

The COVID-19 booster programme will begin in care homes and for housebound patients...

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...